CF PHjson TECH (02652) spent 218,000 Hong Kong dollars to repurchase 9500 shares on March 31.
Changfeng Pharmaceutical (02652) announced that on March 31, 2026, it spent 218,000 Hong Kong dollars to repurchase 9,500 shares.
CF Pharmtech (02652) announced a share buyback of 9500 shares at a cost of 218,000 Hong Kong dollars on March 31, 2026.
Related Articles
Spring Airlines' controlling shareholder proposes to repurchase the company's shares for 300 million to 500 million yuan.
Lan Arrow Aerospace, China Salt Group and other 27 companies' IPO review status on the Shanghai Stock Exchange has been changed to "suspended (financial report update)".
KINGWORLD (01110) released its annual performance with a net profit attributable to shareholders of 11.282 million yuan, a decrease of 72.9% year-on-year.
Spring Airlines' controlling shareholder proposes to repurchase the company's shares for 300 million to 500 million yuan.
Lan Arrow Aerospace, China Salt Group and other 27 companies' IPO review status on the Shanghai Stock Exchange has been changed to "suspended (financial report update)".
KINGWORLD (01110) released its annual performance with a net profit attributable to shareholders of 11.282 million yuan, a decrease of 72.9% year-on-year.
RECOMMEND
Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026
Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026
Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026
